Literature DB >> 25196644

Evaluation of inhibitory effects of caffeic acid and quercetin on human liver cytochrome p450 activities.

Himanshu Rastogi1, Snehasis Jana.   

Abstract

When herbal drugs and conventional allopathic drugs are used together, they can interact in our body which can lead to the potential for herb-drug interactions. This work was conducted to evaluate the herb-drug interaction potential of caffeic acid and quercetin mediated by cytochrome P450 (CYP) inhibition. Human liver microsomes (HLMs) were added to each selective probe substrates of cytochrome P450 enzymes with or without of caffeic acid and quercetin. IC50 , Ki values, and the types of inhibition were determined. Both caffeic acid and quercetin were potent competitive inhibitors of CYP1A2 (Ki = 1.16 and 0.93 μM, respectively) and CYP2C9 (Ki = 0.95 and 1.67 μM, respectively). Caffeic acid was a potent competitive inhibitor of CYP2D6 (Ki = 1.10 μM) and a weak inhibitor of CYP2C19 and CYP3A4 (IC50  > 100 μM). Quercetin was a potent competitive inhibitor of CYP 2C19 and CYP3A4 (Ki = 1.74 and 4.12 μM, respectively) and a moderate competitive inhibitor of CYP2D6 (Ki = 18.72 μM). These findings might be helpful for safe and effective use of polyphenols in clinical practice. Our data indicated that it is necessary to study the in vivo interactions between drugs and pharmaceuticals with dietary polyphenols.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  caffeic acid; cytochrome P450 inhibition; herb-drug interaction; human liver microsomes; polyphenols; quercetin

Mesh:

Substances:

Year:  2014        PMID: 25196644     DOI: 10.1002/ptr.5220

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  14 in total

1.  Effects of Caffeic Acid and Quercetin on In Vitro Permeability, Metabolism and In Vivo Pharmacokinetics of Melatonin in Rats: Potential for Herb-Drug Interaction.

Authors:  Snehasis Jana; Himanshu Rastogi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-10       Impact factor: 2.441

2.  Effect of Dietary Doses of Quercetin on Hepatic Drug Metabolizing Enzymes in Spontaneously Hypertensive Rats.

Authors:  Fawzy Elbarbry; Aimy Ung; Deepa Rao; Khaled Abdelkawy
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2019-12       Impact factor: 2.441

3.  Effect of Myricetin on CYP2C8 Inhibition to Assess the Likelihood of Drug Interaction Using In Silico, In Vitro, and In Vivo Approaches.

Authors:  Shipra Bhatt; Diksha Manhas; Vinay Kumar; Abhishek Gour; Kuhu Sharma; Ashish Dogra; Probir Kumar Ojha; Utpal Nandi
Journal:  ACS Omega       Date:  2022-04-04

4.  Effect of an ethanol extract of Descurainia sophia seeds on Phase I and II drug metabolizing enzymes and P-glycoprotein activity in vitro.

Authors:  Jin-Mu Yi; Young Ah Kim; You Jin Lee; Ok-Sun Bang; No Soo Kim
Journal:  BMC Complement Altern Med       Date:  2015-12-18       Impact factor: 3.659

5.  Studying the Inhibitory Effect of Quercetin and Thymoquinone on Human Cytochrome P450 Enzyme Activities.

Authors:  Fawzy Elbarbry; Aimy Ung; Khaled Abdelkawy
Journal:  Pharmacogn Mag       Date:  2018-01-31       Impact factor: 1.085

6.  Inhibitory Effect of Sauchinone on UDP-Glucuronosyltransferase (UGT) 2B7 Activity.

Authors:  Byoung Hoon You; Eun Chae Gong; Young Hee Choi
Journal:  Molecules       Date:  2018-02-09       Impact factor: 4.411

7.  Isolation and Expression Analysis of CYP9A11 and Cytochrome P450 Reductase Gene in the Beet Armyworm (Lepidoptera: Noctuidae).

Authors:  Chunqing Zhao; Xiaoyun Feng; Tao Tang; Lihong Qiu
Journal:  J Insect Sci       Date:  2015-08-28       Impact factor: 1.857

8.  Impact of quercetin‑induced changes in drug‑metabolizing enzyme and transporter expression on the pharmacokinetics of cyclosporine in rats.

Authors:  Yani Liu; Xiaomei Luo; Chunxiao Yang; Tingyu Yang; Jiali Zhou; Shaojun Shi
Journal:  Mol Med Rep       Date:  2016-08-09       Impact factor: 2.952

9.  Inhibitory Effects of Quercetin and Its Main Methyl, Sulfate, and Glucuronic Acid Conjugates on Cytochrome P450 Enzymes, and on OATP, BCRP and MRP2 Transporters.

Authors:  Violetta Mohos; Eszter Fliszár-Nyúl; Orsolya Ungvári; Katalin Kuffa; Paul W Needs; Paul A Kroon; Ágnes Telbisz; Csilla Özvegy-Laczka; Miklós Poór
Journal:  Nutrients       Date:  2020-07-31       Impact factor: 5.717

10.  Quercetin‑3‑O‑β‑D‑glucoside decreases the bioavailability of cyclosporin A through regulation of drug metabolizing enzymes, transporters and nuclear receptors in rats.

Authors:  Tingyu Yang; Yani Liu; Xixi Huang; Rui Zhang; Chunxiao Yang; Jiali Zhou; Yu Zhang; Jing Wan; Shaojun Shi
Journal:  Mol Med Rep       Date:  2018-07-03       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.